4-YEARS RESISTANCE TRENDLINE BROKEN AND THE SCRIPT HAS GIVEN A RETRACEMENT. GOOD TO ACCUMULATE FOR SWING AND LONG TERM. TARGETS 310 AND 350.
HindZinc Triangle breakout and retest done perfectly. Rsi breakout and retest. Target- 380-383 Follow for more.
Chart is self explanatory. Entry, Targets and Stop Loss are mentioned on the chart. Disclaimer: This is for demonstration and educational purpose only. This is not buying or selling recommendations. I am not SEBI registered. Please consult your financial advisor before taking any trade.
Details on Chart. Note: This is for educational purpose only
Bull-flag pattern can be spotted on the daily time frame. A price breakout supported by humongous volumes can be seen on the chart today With an appropriate SL one can expect price moves upto ~3500 level.
In this chart it is moving in sideways if it breaks "Support Level" then our first target would be $1.4226 and after that $1.39 but if it breaks "Resistance Level" than our first target would be $1.49 and after that $1.52. So just wait for breakout and if want check our results than you can check our previous charts results.
Triangle pattern breakout and retest in MEDICAMEN BIOTECH LTD First target : 750 SL : 560
Positional Trade: Vinyl Chemicals CMP: 163 Target: 180 Stop Loss: 154
Buy at CMP 776 or in the range of (765-775) Chart features :- 1. Flag & pole breakout. 2. Fibo support of 0.236 Additional feature of increase in sales since a couple of quarters. Target of 900 in short term with risk reward of 1 : 2.36
This is follow-up on BSE. Can check link to related ideas. Target 1 achieved. More than 60%. Target 2 is ON. Chart is self explanatory. Entry, Targets and Trailing Stop Loss are mentioned on the chart. Disclaimer: This is for demonstration and educational purpose only. This is not buying or selling recommendations. I am not SEBI registered. Please consult your...
Positional Trade: HT Media is developing a Cup and Handle Pattern. CMP: 28.75 Stop Loss: 26 Target: 37
Praj Industries (Nse) has an operating revenue of Rs. 1,304.67 Cr. on a trailing 12-month basis. Annual revenue growth of 17% is outstanding, a Pre-tax margin of 9% is okay, ROE of 10% is good. The company is debt-free and has a strong balance sheet enabling it to report stable earnings growth across business cycles.